Graft-versus-host disease (GVHD) is an immune-mediated disease, which results from a multifaceted interaction amongst donor and recipient's adaptive immunity. GVHD is an induced indication and emerges post organ or tissue transplant. The probability of developing GVHD is higher in allogeneic transplant, a transplant where donor's organ/cell are used for transplantation compared with autologous transplant, a transplant where individual's cells have been used for transplant.
Covered in this report
The report covers the present scenario and the growth prospects of the global graft vs host disease (GVHD) treatment market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To access full, click here: [color=#ff0000]https://www.radiantinsights.com/research/global-graft-vs-host-disease-gvhd-treatment-market-2017-2021[/color]
Global Graft vs Host Disease (GVHD) Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Bristol-Myers Squibb
Novartis
Pfizer
F. Hoffmann-La Roche
Other prominent vendors
Abbott
AbbVie
Allergan
Anterogen
Astellas Pharma
Athersys
Baxter
Caladrius
Cellular Biomedicine Group
Cipla
Eisai
Eli Lilly
GlaxoSmithKline
Glenmark
Helsinn Healthcare
Heron Therapeutics
Incyte Corporation
IPCA Laboratories
Kadmon Holdings
Lupin
Osiris Therapeutics
RedHill
Sanofi
Shire
Sun Pharmaceutical Industries
Takeda Pharmaceutical
ViaCyte
Request free sample copy of this report @ [color=#ff0000]https://www.radiantinsights.com/research/global-graft-vs-host-disease-gvhd-treatment-market-2017-2021/request-sample[/color]
Market driver
Increased prevalence of cancer
For a full, detailed list, view our report
Market challenge
Off-label use of drugs
For a full, detailed list, view our report
Market trend
Inorganic growth strategies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?